Although fibroblast growth factor receptor 1 (FGFR1) has been implicated in activating TBXT expression in lung cancer through MAPK signaling [16], the genomic cis‐regulatory regions that mediate this activation are unknown. Here, FGFR1 is linked to lung carcinoma.